Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Capital Employed (2016 - 2026)

Ironwood Pharmaceuticals' Return on Capital Employed history spans 15 years, with the latest figure at 9.53% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed fell 1857.0% to 9.53% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.53%, a 1857.0% decrease, with the full-year FY2025 number at 11.17%, down 1386.0% from a year prior.
  • Return on Capital Employed hit 9.53% in Q4 2025 for Ironwood Pharmaceuticals, down from 97.0% in the prior quarter.
  • Over the last five years, Return on Capital Employed for IRWD hit a ceiling of 246.38% in Q3 2024 and a floor of 323.13% in Q3 2023.
  • Historically, Return on Capital Employed has averaged 5.67% across 5 years, with a median of 10.91% in 2021.
  • Biggest five-year swings in Return on Capital Employed: tumbled -32807bps in 2023 and later surged 56951bps in 2024.
  • Tracing IRWD's Return on Capital Employed over 5 years: stood at 4.48% in 2021, then soared by 435bps to 23.96% in 2022, then crashed by -475bps to 89.9% in 2023, then skyrocketed by 131bps to 28.1% in 2024, then plummeted by -66bps to 9.53% in 2025.
  • Business Quant data shows Return on Capital Employed for IRWD at 9.53% in Q4 2025, 97.0% in Q3 2025, and 71.51% in Q2 2025.